Today’s Stock Alert: Could Stellar Biotechnologies Inc See a Reversal After This Very Strong Session?

Today's Stock Alert: Could Stellar Biotechnologies Inc See a Reversal After This Very Strong Session?

The stock of Stellar Biotechnologies Inc (NASDAQ:SBOT) is a huge mover today! About 92,142 shares traded hands or 110.78% up from the average. Stellar Biotechnologies Inc (NASDAQ:SBOT) has declined 48.03% since April 28, 2016 and is downtrending. It has underperformed by 53.96% the S&P500.
The move comes after 9 months positive chart setup for the $21.90M company. It was reported on Dec, 1 by Barchart.com. We have $2.11 PT which if reached, will make NASDAQ:SBOT worth $657,000 more.

Analysts await Stellar Biotechnologies Inc (NASDAQ:SBOT) to report earnings on December, 12. They expect $-0.14 earnings per share, up 26.32% or $0.05 from last year’s $-0.19 per share. After $-0.14 actual earnings per share reported by Stellar Biotechnologies Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

According to Zacks Investment Research, “Stellar Biotechnologies, Inc. is engaged in the development, manufacture and commercialization of keyhole limpet hemocyanin and technologies. The Company’s principle products consist of: stellar KLH protein and stellar KLH ELISA Kits. KLH is a component for cancer vaccines and anticipated therapeutic vaccines, including those for lymphoma, sarcoma, small cell lung cancer, Alzheimer’s disease, rheumatoid arthritis, lupus and Post Traumatic Stress Disorder chemical dependencies. It operates primarily in the United States, Europe, and Asia. Stellar Biotechnologies, Inc. is headquartered in Port Hueneme, California.”

More recent Stellar Biotechnologies Inc (NASDAQ:SBOT) news were published by: Marketwatch.com which released: “Stellar Biotechnologies stock price target cut to $7 from $17 at Maxim Group” on November 05, 2015. Also Seekingalpha.com published the news titled: “Stellar Biotechnologies: Vaccine Tech Buoyed By Partnerships” on June 23, 2016. Marketwired.com‘s news article titled: “Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference” with publication date: December 01, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment